Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
---|---|---|---|---|---|---|---|
Feb 13, 2015 | SVP, GM - Oncology | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 18,100 | -- | -- | |
Jan 28, 2015 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 419 | $19.42 | 28,701 | |
Dec 01, 2014 | EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,856 | $17.45 | 33,913 | |
Nov 17, 2014 | SVP, Business Development | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,392 | $16.85 | 30,062 | |
Nov 10, 2014 | SVP and General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 25,765 | |
Nov 10, 2014 | SVP and General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
Nov 10, 2014 | SVP and General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
Nov 10, 2014 | SVP and General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
Nov 10, 2014 | SVP and General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
Nov 10, 2014 | SVP and General Counsel | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.